Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia-ischemia

Journal of Neurochemistry

Volumn 108, Issue 3, 2009, Pages 552-562

  Ginet, Vanessa ^a,b   Puyal, Julien ^b   Magnin, Guylène ^a,b   Clarke, Peter G H ^b   Truttmann, Anita C ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Hypoxic ischemic encephalopathy; Mitogen activated protein kinase signaling pathway; Neuroprotection; Newborn; Peptides; Rat

Indexed keywords

CALPAIN; CASPASE 3; D JUN N KINASE INHIBITOR 1; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BRAIN HYPOXIA; BRAIN ISCHEMIA; CAROTID ARTERY LIGATION; CELL DEATH; COMMON CAROTID ARTERY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MALE; NEUROPROTECTION; NEWBORN; NONHUMAN; ONCOGENE C FOS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THALAMUS; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; ASPHYXIA; AUTOPHAGY; BLOTTING, WESTERN; BRAIN; CALPAIN; CASPASE 3; ENZYME ACTIVATION; GENE EXPRESSION; GENES, FOS; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; PEPTIDES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MUS; RATTUS;

EID: 58149328524     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05797.x     Document Type: Article

References (53)

1. Adhami F., Yu D., Yin W., Schloemer A., Burns K. A., Liao G., Degen J. L., Chen J. Kuan C. Y. (2008) Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia. Am. J. Pathol. 172, 1704 1716.
2. Arthur P. G., Matich G. P., Pang W. W., Yu D. Y. Bogoyevitch M. A. (2007) Necrotic death of neurons following an excitotoxic insult is prevented by a peptide inhibitor of c-jun N-terminal kinase. J. Neurochem. 102, 65 76.
3. Bogoyevitch M. A. (2006) The isoform-specific functions of the c-jun N-terminal kinases (JNKs): differences revealed by gene targeting. Bioessays 28, 923 934.
4. Bonny C., Oberson A., Negri S., Sauser C. Schorderet D. F. (2001) Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 50, 77 82.
5. Borsello T., Clarke P. G. H., Hirt L., Vercelli A., Repici M., Schorderet D. F., Bogousslavsky J. Bonny C. (2003a) A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9, 1180 1186.
6. Borsello T., Croquelois K., Hornung J. P. Clarke P. G. H. (2003b) N-methyl-D-aspartate-triggered neuronal death in organotypic hippocampal cultures is endocytic, autophagic and mediated by c-jun N-terminal kinase pathway. Eur. J. Neurosci. 18, 473 485.
7. Brecht S., Kirchhof R., Chromik A. et al. (2005) Specific pathophysiological functions of JNK isoforms in the brain. Eur. J. Neurosci. 21, 363 377.
8. Cavigelli M., Dolfi F., Claret F. X. Karin M. (1995) Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14, 5957 5964.
9. Centeno C., Repici M., Chatton J. Y. et al. (2006) Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons. Cell Death Diff. 14, 240 531.
10. Enomoto A., Suzuki N., Morita A., Ito M., Liu C. Q., Matsumoto Y., Yoshioka K., Shiba T. Hosoi Y. (2003) Caspase-mediated cleavage of JNK during stress-induced apoptosis. Biochem. Biophys. Res. Commun. 306, 837 842.
11. Fellman V. Raivio K. O. (1997) Reperfusion injury as the mechanism of brain damage after perinatal asphyxia. Pediatr. Res. 41, 599 606.
12. Ferdaoussi M., Abdelli S., Yang J. Y. et al. (2008) Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Diabetes 57, 1205 1215.
13. Guan Q. H., Pei D. S., Liu X. M., Wang X. T., Xu T. L. Zhang G. Y. (2006a) Neuroprotection against ischemic brain injury by SP600125 via suppressing the extrinsic and intrinsic pathways of apoptosis. Brain Res. 1092, 36 46.
14. Guan Q. H., Pei D. S., Zong Y. Y., Xu T. L. Zhang G. Y. (2006b) Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways. Neuroscience 139, 609 627.
15. Gubits R. M., Burke R. E., Casey-McIntosh G., Bandele A. Munell F. (1993) Immediate early gene induction after neonatal hypoxia-ischemia. Mol. Brain Res. 18, 228 238.
16. Gupta S., Barrett T., Whitmarsh A. J., Cavanagh J., Sluss H. K., Dérijard B. Davis R. J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760 2770.
17. Hee Han B., Choi J. Holtzman D. M. (2002) Evidence that p38 mitogen-activated protein kinase contributes to neonatal hypoxic-ischemic brain injury. Dev. Neurosci. 24, 405 410.
18. Herdegen T. Leah J. D. (1998) Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 28, 370 490.
19. Hirt L., Badaut J., Thevenet J., Granziera C., Regli L., Maurer F., Bonny C. Bogousslavsky J. (2004) d-JNKI1, a cell-penetrating JNK inhibitor, protects against cell death in severe cerebral ischemia. Stroke 35, 1738 1743.
20. Humar M., Loop T., Schmidt R., Hoetzel A., Roesslein M., Andriopoulos N., Pahl H. L., Geiger K. K. Pannen B. H. (2007) The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun. Int. J. Biochem. Cell Biol. 39, 2278 2288.
21. Jacobs S., Hunt R., Tarnow-Mordi W., Inder T. Davis P. (2007) Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev. 4, CD003311.
22. Johnston M. V., Trescher W. H., Ishida A. Nakajima W. (2003) Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res. 49, 735 741.
23. Koike M., Shibata M., Tadakoshi M. et al. (2008) Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury. Am. J. Pathol. 172, 454 469.
24. Kuan C. Y., Whitmarsh A. J., Yang D. D. et al. (2003) A critical role of neural-specific JNK3 for ischemic apoptosis. Proc. Natl Acad. Sci. USA 100, 15184 15189.
25. Leppä S., Saffrich R., Ansorge W. Bohmann D. (1998) Differential regulation of c-Jun by ERK and JNK during PC12 cell differentiation. EMBO J. 17, 4404 4413.
26. Macaya A., Munell F., Ferrer I., de Torres C. Reventós J. (1998) Cell death and associated c-jun induction in perinatal hypoxia-ischemia. Effect of the neuroprotective drug dexamethasone. Mol. Brain Res. 56, 29 37.
27. Nijboer C. H., Heijnen C. J., Groenendaal F., May M. J., van Bel F. Kavelaars A. (2008) Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 39, 2129 2137.
28. Noor J. I., Ikeda T., Mishima K., Aoo N., Ohta S., Egashira N., Iwasaki K., Fujiwara M. Ikenoue T. (2005) Short-term administration of a new free radical scavenger, edaravone, is more effective than its long-term administration for the treatment of neonatal hypoxic-ischemic encephalopathy. Stroke 36, 2468 2474.
29. Northington F. J., Graham E. M. Martin L. J. (2005) Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited? Brain Res. Brain Res. Rev. 50, 244 257.
30. Palmer C., Towfighi J., Roberts R. L. Heitjan D. F. (1993) Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr. Res. 33, 405 411.
31. Pirianov G., Brywe K. G., Mallard C., Edwards A. D., Flavell R. A., Hagberg H. Mehmet H. (2007) Deletion of the c-jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury. J. Cerebral Blood Flow Met. 27, 1022 1032.
32. Raivich G. Behrens A. (2006) Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Prog. Neurobiol. 78, 347 363.
33. Renolleau S., Fau S. Charriaut-Marlangue C. (2008) Gender-related differences in apoptotic pathways after neonatal cerebral ischemia. Neuroscientist 14, 46 52.
34. Repici M., Centeno C., Tomasi S., Forloni G., Bonny C., Vercelli A. Borsello T. (2007) Time-course of c-jun N-terminal kinase activation after cerebral ischemia and effects of d-JNKI1 on c-jun and caspase-3 activation. Neuroscience 150, 40 49.
35. Rice J. E., Vannucci R. C. Brierley J. B. (1981) The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9, 131 141.
36. Shimizu K., Rajapakse N., Horiguchi T., Payne R. M. Busija D. W. (2003) Neuroprotection against hypoxia-ischemia in neonatal rat brain by novel superoxide dismutase mimetics. Neurosci. Lett. 346, 41 44.
37. Shintani T. Klionsky D. J. (2004) Autophagy in health and disease: a double-edged sword. Science 306, 990 995.
38. Siman R., Baudry M. Lynch G. (1984) Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease. Proc. Natl Acad. Sci. USA 81, 3572 3576.
39. Soriano F. X., Martel M.-A., Papadia S. et al. (2008) Specific targeting of pro-death NMDA receptor signals with differing reliance on the NR2B PDZ ligand. J. Neurosci. 28, 10696 10710.
40. van den Tweel E. R., Kavelaars A., Lombardi M. S., Nijboer C. H., Groenendaal F., van Bel F. Heijnen C. J. (2006) Bilateral molecular changes in a neonatal rat model of unilateral hypoxic-ischemic brain damage. Pediatr. Res. 59, 434 439.
41. Uchiyama Y., Koike M. Shibata M. (2008) Autophagic neuron death in neonatal brain ischemia/hypoxia. Autophagy 4, 1 5.
42. Vannucci R. C. Vannucci S. J. (1997) A model of perinatal hypoxic-ischemic brain damage. Ann. NY Acad. Sci. 835, 234 249.
43. Vannucci R. C., Towfighi J. Vannucci S. J. (2004) Secondary energy failure after cerebral hypoxia-ischemia in the immature rat. J. Cereb. Blood Flow Metab. 24, 1090 1097.
44. Vaslin A., Puyal J., Borsello T. Clarke P. G. H. (2007) Excitotoxicity-related endocytosis in cortical neurons. J. Neurochem. 102, 789 800.
45. Volpe J. J. (2001) Perinatal brain injury: from pathogenesis to neuroprotection. Ment. Retard. Dev. Disabil. Res. Rev. 7, 56 64.
46. Waetzig V. Herdegen T. (2005) Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends Pharm. Sci. 26, 455 598.
47. Waetzig V., Zhao Y. Herdegen T. (2006) The bright side of JNKs-multitalented mediators in neuronal sprouting, brain development and nerve fiber regeneration. Prog. Neurobiol. 80, 84 97.
48. Wang K. K. (2000) Calpain and caspase: can you tell the difference? Trends Neurosci. 23, 20 26.
49. Wang J., Ruel J., Ladrech S., Bonny C., van de Water T. R. Puel J. L. (2007) Inhibition of the c-Jun N-terminal kinase-mediated mitochondrial cell death pathway restores auditory function in sound-exposed animals. Mol. Pharmacol. 71, 654 666.
50. Wiegler K., Bonny C., Coquoz D. Hirt L. (2008) The JNK Inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator. Cerebrovasc. Dis. 26, 360 366.
51. Yang D. D., Kuan C. Y., Whitmarsh A. J., Rincón M., Zheng T. S., Davis R. J., Rakic P. Flavell R. A. (1997) Absence of excitotoxicity induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865 870.
52. Yang J. Y., Moulin N., van Bemmelen M. X., Dubuis G., Tawadros T., Haefliger J. A., Waeber G. Widmann C. (2007) Splice variant-specific stabilization of JNKs by IB1/JIP1. Cell. Signal. 19, 2201 2207.
53. Zhu C., Wang X., Xu F., Bahr B. A., Shibata M., Uchiyama Y., Hagberg H. Blomgren K. (2005) The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Diff. 12, 162 176.